Polsinelli Represents Sevaro Health, Inc. in $39 Million Series B Financing

Polsinelli congratulates its client, Sevaro Health, Inc., on its $39 Million Series B financing. Sevaro Health is a physician-led virtual neurology company dedicated to making world-class neurological care accessible everywhere through cutting-edge technology, compassionate service, and a full suite of tele-neurology solutions for hospitals and patients worldwide.

The financing was led by Valtruis and Intermountain Ventures, among others. The financing will help fuel Sevaro Health’s continued growth in virtual neurology by expanding its AI-powered Synapse platform, broadening subspecialty coverage, and supporting nationwide hospital partners with faster, more sustainable care. It will also back leadership hires, data and analytics innovation, and Sevaro Health’s mission to make world-class neurological care accessible to every patient.

More information about the financing can be obtained from Sevaro Health’s announcement.

The Polsinelli Venture Capital and Emerging Growth Companies team involved in the transaction included Paul D. Squire, Mark Cloutier, Nicola DeVita and Cole Anthony.